COVID Rounds: EU Episode 1

CME

COVID-19 in the EU: Current Trends and Risk Factors for Severe COVID-19 Progression

European Learners: 0.25 hours EBAC® effective education time

Released: February 05, 2025

Expiration: February 04, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Your patient, who is 65 years of age with a history of lymphoma treated with rituximab-containing chemotherapy (received in the past 3 months), presents to an emergency department after a fall. The patient is found to have mild COVID-19 (not requiring oxygen). The patient received 2 doses of an mRNA COVID-19 vaccine 3 years ago, but no booster doses. 

Which of the following factors put the patient at high risk for COVID-19 progression?